News Search Results
Sep 20, 2026, 16:00 ET Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
such therapies. The company's broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, neurology, endocrinology, ophthalmology and dermatology, although it is not confined to these areas. Additional information can be found at
More news about: Specialised Therapeutics
Sep 20, 2026, 08:23 ET S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
dedicated to pursuing scientific breakthroughs that improve people's lives. The company focuses on immunology, oncology, neurology, rare diseases, ophthalmology and vaccines, and maintains a significant R&D and commercial presence in China, where it has long invested in partnerships with local academic
More news about: Qiming Venture Partners
Sep 20, 2026, 08:18 ET S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
dedicated to pursuing scientific breakthroughs that improve people's lives. The company focuses on immunology, oncology, neurology, rare diseases, ophthalmology and vaccines, and maintains a significant R&D and commercial presence in China, where it has long invested in partnerships with local academic
More news about: Qiming Venture Partners
Sep 17, 2026, 09:00 ET ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300
fully automated, multimodal device to the ZEISS OCT portfolio, complementing the comprehensive CIRRUS solution," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology."Many practices are looking for ways to integrate retinal imaging into everyday patient
More news about: Carl Zeiss Meditec AG
Sep 17, 2026, 09:00 ET ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300
fully automated, multimodal device to the ZEISS OCT portfolio, complementing the comprehensive CIRRUS solution," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology."Many practices are looking for ways to integrate retinal imaging into everyday patient
More news about: Carl Zeiss Meditec AG
Sep 17, 2026, 08:30 ET Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
in the US as well as Global Emerging Markets. Sun's high growth Global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and oncodermatology and accounts for about 22% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Sep 17, 2026, 03:05 ET Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
Huang, Director of Research & Associate Director, Casey Eye Institute; WoldFamily Endowed Chair in Ophthalmic Imaging; Professor of Ophthalmology &Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, UnitedStates; Director, Center for Ophthalmic
More news about: Clarivate Plc
Sep 17, 2026, 03:05 ET Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
Huang, Director of Research & Associate Director, Casey Eye Institute; WoldFamily Endowed Chair in Ophthalmic Imaging; Professor of Ophthalmology &Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, UnitedStates; Director, Center for Ophthalmic
More news about: Clarivate Plc
Sep 16, 2026, 10:28 ET Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.For more information, visit: Piramal
More news about: Piramal Pharma Solutions
Sep 16, 2026, 10:14 ET Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.For more information, visit: Piramal
More news about: Piramal Pharma Solutions
Sep 15, 2026, 11:02 ET Salt Lake City Oculofacial Plastic Surgeon Dr. Kian Eftekhari Named a 2026 Salt Lake Magazine Top Doctor
Board of Ophthalmology and completed an accredited two-year fellowship in oculoplastic and facial surgery through the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). He founded the Eyelid Center of Utah in 2019 after serving as Assistant Professor of Ophthalmology at the Kittner
More news about: Eyelid Center of Utah
Sep 15, 2026, 09:00 ET Century Health and Eye Health America to Unlock a Decade of Real-World Data to Advance Chronic Retinal Disease Research
researchCentury Health's AI model, CHARM, will enable access to over a decade of disease progression data locked inside ophthalmology records, notes and attachmentsThe partnership will create one of the most detailed longitudinal datasets on chronic
More news about: Century Health
Sep 14, 2026, 11:00 ET ABMS Announces a Record Number of ABMS Scholars for the 2026-2027 Cohort
activities (EPAs)American Board of OphthalmologyAmy Zhang, MD – University of MichiganProject: Initial Certification Timing, Pass Rate and Preparation Experiences in Ophthalmology Board CertificationAmerican Board
More news about: American Board of Medical Specialties
Sep 11, 2026, 21:26 ET PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study
follows validation studies of AIM tests across a range of visual functions and patient populations, published in journals including Investigative Ophthalmology & Visual Science, Optometry and Vision Science, and — earlier this month — Scientific Reports. The Phase I project will generate
More news about: PerZeption
Sep 10, 2026, 14:43 ET ZEISS Industrial Quality Solutions USA Announces New Leadership to Support Growing Customer Demand
assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture
More news about: Carl Zeiss Industrial Quality Solutions, LLC
Sep 10, 2026, 08:00 ET ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL - the ZEISS AT LUCIA toric 721P
portfolio will provide surgeons around the world with more options to reach a higher level of patient satisfaction," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology."Providing high reliability and proven lens platform stability, the ZEISS AT LUCIA toric
More news about: Carl Zeiss Meditec AG
Sep 10, 2026, 08:00 ET ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL - the ZEISS AT LUCIA toric 721P
portfolio will provide surgeons around the world with more options to reach a higher level of patient satisfaction," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology."Providing high reliability and proven lens platform stability, the ZEISS AT LUCIA toric
More news about: Carl Zeiss Meditec AG
Sep 10, 2026, 07:00 ET XpertDox Strengthens Sales and Partnership Leadership as AI Medical Coding Adoption Scales
and fee-for-service (FFS) coding.XpertDox serves FQHCs, primary care, pediatric, women's health, behavioral health, dental, orthopedic, ophthalmology, urgent care, home health, family services, multispecialty groups, and health systems. XpertDox also partners with Healthcare GPOs, MSOs, and RCM
More news about: XpertDox
Sep 09, 2026, 08:05 ET InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Press
More news about: InMode Ltd.
Sep 09, 2026, 07:03 ET Nanoscope Therapeutics Announces U.S. Food and Drug Administration Acceptance of Biologics License Application for MOGENRY for the Treatment of Retinitis Pigmentosa with Severe Vision Loss
new era of RP treatment within reach of patients who do not have access to a tertiary academic center," said Allen C. Ho, M.D., Professor of Ophthalmology, Thomas Jefferson University and Director of Retina Research, Wills Eye Hospital, and Chief Medical Advisor for Nanoscope Therapeutics. Most
More news about: Nanoscope Therapeutics
Sep 07, 2026, 14:26 ET In HelloNation, Eye Care Experts, Dr. Singh, and Dr. Sanka of Eye Centers of Racine and Kenosha, explain how interventional ophthalmology is changing treatment
an article that answers this question by examining how interventional ophthalmology helps patients address eye disease earlier and preserve long-term vision.
More news about: HelloNation
Sep 03, 2026, 09:45 ET Ohio's Governor Mike DeWine Named Recipient of the 12th Annual Bonnie Strickland Champion for Children's Vision Award, Presented by the National Center for Children's Vision and Eye Health at Prevent Blindness
Truffles the Kitty Organization; and Donny W. Suh, MD, FAAP, MBA, FACS, Chief of Pediatric Ophthalmology and Strabismus, and Professor, Department of Ophthalmology and Visual Science, at
More news about: Prevent Blindness
Sep 03, 2026, 09:45 ET One Health Partners Unveils New Brand, Offering Specialty Physicians a Nonprofit Alternative to Private Equity
compete and grow. The organization currently focuses on specialties that address complex disease management, including rheumatology, dermatology, ophthalmology, neurology, and infectious disease.The approach is designed to strengthen what is already working within a practice while taking on the operational
More news about: One Health Partners
Sep 03, 2026, 09:00 ET ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
clinicians with advanced optical and visualization technology and supporting more efficient, data-driven care," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology.ZEISS Cataract Workflow advancementsZEISS will highlight its latest IOL offering at
More news about: Carl Zeiss Meditec AG
Sep 03, 2026, 09:00 ET ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
clinicians with advanced optical and visualization technology and supporting more efficient, data-driven care," says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology.ZEISS Cataract Workflow advancementsZEISS will highlight its latest IOL offering at
More news about: Carl Zeiss Meditec AG